Manufacturer of Controlled Substances; Notice of Application, 40331-40332 [E7-14266]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 141 / Tuesday, July 24, 2007 / Notices
40331
activity of the group research project.
Membership in this group research
project remains open, and IMS Global
Learning Consortium, Inc. intends to file
additional written notifications
disclosing all changes in membership.
On April 7, 2000, IMS Global
Learning Consortium, Inc. filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on September 13, 2000 (65 FR
55283).
The last notification was filed with
the Department on March 16, 2007. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on May 7, 2007 (72 FR 25781).
Schedule
and Explosives Programs Division
(AEPD) of the Bureau of Alcohol,
Tobacco, Firearms and Explosives
distributes program-specific customer
satisfaction surveys to more effectively
capture customer perception/
satisfaction of services. AEPD’s strategy
is based on a commitment to provide
the kind of customer service that will
better accomplish ATF’s mission.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 500
respondents will complete a 15 minute
survey.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 125
annual total burden hours associated
with this collection.
If additional information is required
contact Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: July 18, 2007.
Lynn Bryant,
Department Clearance Officer, PRA,
Department of Justice.
[FR Doc. E7–14244 Filed 7–23–07; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Antitrust Division
mstockstill on PROD1PC66 with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—IMS Global Learning
Consortium, Inc.
Notice is hereby given that, on June
15, 2007, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), IMS Global Learning
Consortium, Inc. has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Agilix, Orem, UT; Florida
Virtual Schools, Orlando, FL; Houghton
Mifflin Company, Boston, MA; Sungard
Higher Education, Malvern, PA; and
Sun Microsystems, Inc., Broomfield, CO
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
VerDate Aug<31>2005
17:50 Jul 23, 2007
Jkt 211001
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 07–3592 Filed 7–23–07; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on May 23, 2007,
American Radiolabeled Chemical, Inc.,
101 Arc Drive, St. Louis, Missouri
63146, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
Drug
Dextropropoxyphene, bulk (nondosage forms)(9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Phenazocine (9715) .....................
Fentanyl (9801) ............................
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 24, 2007.
Dated: July 10, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–14267 Filed 7–23–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
Schedule
Gamma
hydroxybutyric
acid
(2010).
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Dimethyltryptamine (7435) ...........
1-[1-(2-Thienyl) .............................
cyclohexyl]piperidine(7470) ..........
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Metazocine (9240) ........................
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 24, 2007,
Applied Science Labs, Division of
Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College,
Pennsylvania 16801, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I and II:
Drug
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
4-Methylaminorex (cis isomer)
(1590).
Alpha-ethyltryptamine (7249) .......
E:\FR\FM\24JYN1.SGM
24JYN1
Schedule
I
I
I
I
I
40332
Federal Register / Vol. 72, No. 141 / Tuesday, July 24, 2007 / Notices
Drug
Employment and Training
Administration
of the Trade Act of 1974 (‘‘the Act’’) and
are identified in the Appendix to this
notice. Upon receipt of these petitions,
the Director of the Division of Trade
Adjustment Assistance, Employment
and Training Administration, has
instituted investigations pursuant to
Section 221(a) of the Act.
The purpose of each of the
investigations is to determine whether
the workers are eligible to apply for
adjustment assistance under Title II,
Chapter 2, of the Act. The investigations
will further relate, as appropriate, to the
determination of the date on which total
or partial separations began or
threatened to begin and the subdivision
of the firm involved.
The petitioners or any other persons
showing a substantial interest in the
subject matter of the investigations may
request a public hearing, provided such
request is filed in writing with the
Director, Division of Trade Adjustment
Assistance, at the address shown below,
not later than August 3, 2007.
Interested persons are invited to
submit written comments regarding the
subject matter of the investigations to
the Director, Division of Trade
Adjustment Assistance, at the address
shown below, not later than August 3,
2007.
The petitions filed in this case are
available for inspection at the Office of
the Director, Division of Trade
Adjustment Assistance, Employment
and Training Administration, U.S.
Department of Labor, Room C–5311, 200
Constitution Avenue, NW., Washington,
DC 20210.
Investigations Regarding Certifications
of Eligibility To Apply for Worker
Adjustment Assistance and Alternative
Trade Adjustment Assistance
Signed at Washington, DC, this 17th day of
July 2007.
Richard Church,
Certifying Officer, Division of Trade
Adjustment Assistance.
Schedule
Lysergic acid diethylamide (7315)
2,
5-Dimethoxy-4-npropylthiophenethylamine (2C–
T–7) (7348).
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
2–5–Dimethoxy-4ethylamphetamine (7399).
3,4–Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4–Methylenedioxy-Nethylamphetamine (7404).
3,4–
Methylenedioxymethamphetamine (7405).
4–Methoxyamphetamine (7411) ...
Alpha-methyltryptamine
(AMT)
(7432).
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-methoxy-N-,Ndiisopropyltryptamine(5–MeODIPT) (7439).
N-Ethyl-1-phenylcyclohexylamine
(7455).
1-(1–Phenylcyclohexyl)pyrrolidine
(PCPy) (7458).
1[1-(2
Thienyl)cyclohexyl]piperidine
(7470).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Methamphetamine (1105) ............
1–Phenylcylohexylamine (7460) ..
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1–
Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
Drug
Schedule
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Benzoylecgonine (9180) ...............
Meperidine intermediate-B (9233)
Noroxymorphone (9668) ..............
II
II
II
II
II
The company plans to manufacture
high purity drug standards used for
analytical application only in clinical,
toxicological, and forensic laboratories.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 24, 2007.
Dated: July 10, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–14266 Filed 7–23–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Petitions have been filed with the
Secretary of Labor under Section 221(a)
APPENDIX
[TAA petitions instituted between 7/9/07 and 7/13/07]
mstockstill on PROD1PC66 with NOTICES
TA–W
61797
61798
61799
61800
61801
61802
61803
61804
61805
61806
61807
................
................
................
................
................
................
................
................
................
................
................
VerDate Aug<31>2005
Date of
institution
Subject firm (petitioners)
Location
Arrow International (Comp) ..................................................
Ryerson Steel (Wkrs) ...........................................................
Peres Pattern Company (Wkrs) ...........................................
O’Sullivan Industries, Inc. (Comp) ........................................
Alcraft (Comp) ......................................................................
Hofmann Industries, Inc. (Comp) .........................................
Rima Manufacturing Company (Comp) ................................
JT Posey (Wkrs) ...................................................................
Cookson Electronics (IBT) ....................................................
United States Ceramic Tile Company (Comp) .....................
Collins and Aikman (Comp) .................................................
Everett, MA ...........................
Middletown, OH ....................
Erie, PA .................................
Roswell, GA ..........................
Pawtucket, RI ........................
Skinking Spring, PA ..............
Hudson, MI ............................
Arcadia, CA ...........................
Jersey City, NJ ......................
Canton, OH ...........................
Farmington, NH .....................
17:50 Jul 23, 2007
Jkt 211001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\24JYN1.SGM
24JYN1
07/09/07
07/09/07
07/09/07
07/09/07
07/09/07
07/09/07
07/09/07
07/09/07
07/10/07
07/10/07
07/10/07
Date of
petition
07/05/07
06/27/07
07/06/07
07/06/07
06/28/07
06/25/07
06/14/07
06/28/07
07/10/07
06/12/07
07/09/07
]]>Agencies
[Federal Register Volume 72, Number 141 (Tuesday, July 24, 2007)]
[Notices]
[Pages 40331-40332]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-14266]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 24, 2007, Applied
Science Labs, Division of Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College, Pennsylvania 16801, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
4-Methylaminorex (cis isomer) (1590)....... I
Alpha-ethyltryptamine (7249)............... I
[[Page 40332]]
Lysergic acid diethylamide (7315).......... I
2, 5-Dimethoxy-4-n-propylthiophenethylamine I
(2C-T-7) (7348).
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
2-5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
Alpha-methyltryptamine (AMT) (7432)........ I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-methoxy-N-,N-diisopropyltryptamine(5-MeO- I
DIPT) (7439).
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
1-(1-Phenylcyclohexyl)pyrrolidine (PCPy) I
(7458).
1[1-(2 Thienyl)cyclohexyl]piperidine (7470) I
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Methamphetamine (1105)..................... II
1-Phenylcylohexylamine (7460).............. II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
1-Piperidinocyclohexanecarbonitrile (8603). II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Benzoylecgonine (9180)..................... II
Meperidine intermediate-B (9233)........... II
Noroxymorphone (9668)...................... II
------------------------------------------------------------------------
The company plans to manufacture high purity drug standards used
for analytical application only in clinical, toxicological, and
forensic laboratories.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 2401
Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed
no later than September 24, 2007.
Dated: July 10, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-14266 Filed 7-23-07; 8:45 am]
BILLING CODE 4410-09-P
